Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
70861
Table 1_Nutritionally adequate, healthy, and climate-friendly diets following the Nordic Nutrition Recommendations 2023: an optimization study for Norway.xlsx
Published 2025“…</p>Results<p>Optimizing the diet to meet nutrient and health constraints alone resulted in a modest decrease in GWP (NNR2023); retaining ruminant meat consumption (Ruminant) impeded the reduction (−9% vs. 0%). …”
-
70862
Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization
Published 2016“…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
-
70863
Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization
Published 2016“…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
-
70864
Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization
Published 2016“…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
-
70865
Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization
Published 2016“…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
-
70866
Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization
Published 2016“…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
-
70867
-
70868
Differentiation of mammary gland epithelial cells in control (<i>Ctr</i>) and <i>Miz1</i>Δ<i>POZ</i> tissue and in HC11 cells with reduced levels of Miz1.
Published 2014“…The film was exposed 1 and 5 minutes, respectively. (<b>G</b>) PCR and (<b>H</b>) Western blots revealed a down-regulation of ß-casein when Miz1 concentration is decreased. …”
-
70869
Table_2_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70870
Image_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70871
Image_4_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70872
Image_7_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70873
Table_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70874
Image_1_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.jpeg
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70875
Table_6_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70876
Table_9_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70877
Image_2_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70878
Table_1_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70879
Table_4_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
-
70880
Table_8_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx
Published 2022“…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”